Signature Research Programmes

Synonym(s):

The breast research team in Pathology ACP focuses on 3 main themes of investigation - breast fibroepithelial lesions, triple negative breast cancers, and ductal carcinoma in situ of the breast.

Fibroepithelial lesions encompass the common fibroadenoma and the less frequently encountered phyllodes tumour. The phyllodes tumour resembles the fibroadenoma, although it is associated with a higher likelihood of recurrence in accordance with its grade, with recurrence rates for benign, borderline and malignant phyllodes tumours being 10%, 15% and 20% to 30% respectively (1,2). Malignant phyllodes tumours also possess metastatic potential, and there is a dismal prognosis once metastasis occurs.  We devised a nomogram that helps predict recurrence in an individual patient diagnosed with phyllodes tumour (2). Our team in collaboration with Professor Teh Bin Tean's laboratory discovered a novel mutation in the MED12 gene in fibroadenomas, which lends insight into tumourigenesis of this group of fibroepithelial neoplasms (3). We have also recently published data on the molecular genetics of progression of phyllodes tumours in collaboration with co-investigators from NCCS and Duke-NUS (4).

Triple negative breast cancers are a heterogeneous group of tumours that pose management challenges. They are usually high grade with poorer prognosis. We have pathologically characterised a large cohort of triple negative breast cancers from our Departmental archives (5,6), and are currently interrogating their genetic profiles using the nanostring technique, with focus on immune response genes (7).

Ductal carcinoma in situ (DCIS) of the breast is a non-obligate precursor of invasive disease. Many cases are detected on mammographic screening due to accompanying microcalcifications. While high grade DCIS tends to progress to invasion in a shorter time frame, low grade lesions are also not entirely innocuous. As factors that predict recurrence and invasion are still being debated, our group is interested in determining pathological and biological markers that are able to assist in clinical stratification (8,9).

Apart from these research themes, our group also collaborates on multiple investigations on the biology of breast disease with local and overseas investigators.

Reference:

  1. Tan PH, Jayabaskar T, Chuah KL, Lee HY, Tan Y, Hilmy M, Hung H, Selvarajan S,Bay BH. Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol. 2005 Apr;123(4):529-40.

  2. Tan PH, Thike AA, Tan WJ, Thu MM, Busmanis I, Li H, Chay WY, Tan MH; Phyllodes Tumour Network Singapore. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol. 2012 Jan;65(1):69-76.

  3. Lim WK, Ong CK, Tan J, Thike AA, Ng CC, Rajasegaran V, Myint SS, Nagarajan S, Nasir ND, McPherson JR, Cutcutache I, Poore G, Tay ST, Ooi WS, Tan VK, Hartman M,Ong KW, Tan BK, Rozen SG, Tan PH, Tan P, Teh BT. Exome sequencing identifieshighly recurrent MED12 somatic mutations in breast fibroadenoma. Nat Genet. 2014 Aug;46(8):877-80.

  4. Tan J, Ong CK, Lim WK, Ng CC, Thike AA, Ng LM,  Rajasegaran V, Myint SS, Nagarajan S, Thangaraju S, Dey S, Nasir ND, Wijaya GC, Lim JQ, Huang D, Li Z, Wong BH, Chan JY, McPherson JR, Cutcutache I, Poore G, Tay ST, Tan WJ, Putti TC, Ahmad BS, Iau P, Chan CW, Tang AP, Yong WS, Madhukumar P, Ho GH, Tan VK, Wong CY, Hartman M, Ong KW, Tan BK, Rozen SG, Tan P, Tan PH, Teh BT . Genomic landscapes of breast firbroepithelial tumors. Nat Genet. 2015 Nov 47(11):1341-45.

  5. Thike AA, Iqbal J, Cheok PY, Chong AP, Tse GM, Tan B, Tan P, Wong NS, Tan PH. Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers. Am J Surg Pathol. 2010 Jul;34(7):956-64.

  6. Thike AA, Cheok PY, Jara-Lazaro AR, Tan B, Tan P, Tan PH. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol. 2010 Jan;23(1):123-33.

  7. Matsumoto H, Koo SL, Dent R, Tan PH, Iqbal J. Role of inflammatory infiltrates in triple negative breast cancer. J Clin Pathol. 2015 Mar 6. [Epub ahead of print]

  8. Wong FY, Wang F, Chen JJ, Tan CH, Tan PH. Outcomes of low-risk ductal carcinoma in situ in Southeast Asian women treated with breast conservationtherapy. Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):998-1003.

  9. Thike AA, Iqbal J, Cheok PY, Tse GM, Tan PH. Ductal carcinoma in situ associated with triple negative invasive breast cancer: evidence for a precursor-product relationship. J Clin Pathol. 2013 Aug;66(8):665-70.

The Diagnostic Bacteriology Laboratory performs research in the fields of antimicrobial resistance and molecular typing. Work carried out here has contributed significantly to understanding the local epidemiology of carbapenemase-producing Gram negative bacilli, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci, and Penicillin-resistant Streptococcus pneumoniae. In the past, we have notably provided support for the investigation of outbreaks of eye infection caused by Fusarium spp. and microsporidia. We are also interested in zoonotic infections, virulent community-acquired Klebsiella pneumoniae infections, and the role of the environment in nosocomial infections.

Reference:

  1. Koh TH, Babini GS, Woodford N, Sng LH, Hall LM, Livermore DM.Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore. Lancet. 1999 Jun 19;353(9170):2162.

  2. Hsu LY, Tristan A, Koh TH, Bes M, Etienne J, Kurup A, Tan TT, Tan BH. Community associated methicillin-resistant Staphylococcus aureus, Singapore. Emerg Infect Dis. 2005 Feb;11(2):341-2.

  3. Koh TH, Low BS, Leo N, Hsu LY, Lin RT, Krishnan P, Chan D, Nadarajah M, Toh SL, Ong KH. Molecular epidemiology of vancomycin-resistant enterococci in Singapore. Pathology. 2009;41(7):676-80.

  4. Hsu LY, Lui SW, Lee JL, Hedzlyn HM, Kong DH, Shameen S, Siti NP, Tan WY, Toh XY, Koh TY, Koh TH. Adult invasive pneumococcal disease pre- and peri-pneumococcal conjugate vaccine introduction in a tertiary hospital in Singapore. J Med Microbiol. 2009 Jan;58(Pt 1):101-4.

  5. Jureen R, Koh TH, Wang G, Chai LY, Tan AL, Chai T, Wong YW, Wang Y, Tambyah PA, Beuerman R, Tan D. Use of multiple methods for genotyping Fusarium during an outbreak of contact lens associated fungal keratitis in Singapore. BMC Infect Dis. 2008 Jul 15;8:92.

  6. Tan J, Lee P, Lai Y, Hishamuddin P, Tay J, Tan AL, Chan KS, Lin R, Tan D, Cutter J, Goh KT. Microsporidial keratoconjunctivitis after rugby tournament, Singapore. Emerg Infect Dis. 2013;19(9):1484-6.

  7. Koh TH, Sng LH, Yuen SM, Thomas CK, Tan PL, Tan SH, Wong NS. Streptococcal cellulitis following preparation of fresh raw seafood. Zoonoses Public Health. 2009 May;56(4):206-8.

The Gastrointestinal (GI) team has two main areas of focus: oncology and non-neoplastic diseases.

In GI oncology, there is ongoing research in gastric, pancreatobiliary, liver and colorectal cancers. The team collaborates with scientists in SingHealth and A*Star in the discovery of prognostic and predictive markers. Molecular profiling of both gastric and pancreatobiliary tumours has produced distinctive discoveries in local and regional patients.

In the area of non-neoplastic diseases, the team works closely with hepatologists in liver cirrhosis studies, fatty liver disease and hepatitis. There are ongoing collaborations with Histoindex® in liver fibrosis and steatosis scoring using an advanced tissue imaging system.

Other research interests of the team include Hirschsprung’s disease assessment and gastric dysplasia interpretation.

Reference:

  1. Chia NY, Deng N, Das K, Huang D, Hu L, Zhu Y, Lim KH, Lee MH, Wu J, Sam XX, Tan GS, Wan WK, Yu W, Gan A, Tan AL, Tay ST, Soo KC, Wong WK, Dominguez LT, Ng HH, Rozen S, Goh LK, Teh BT, Tan P. Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development. Gut. 2015 May;64(5):707-19.

  2. Zhou J, Yong WP, Yap CS, Vijayaraghavan A, Sinha RA, Singh BK, Xiu S, Manesh S, Ngo A, Lim A, Ang C, Xie C, Wong FY, Lin SJ, Wan WK, Tan IB, Flotow H, Tan P,  Lim KH, Yen PM, Goh LK. An integrative approach identified genes associated with drug response in gastric cancer. Carcinogenesis. 2015 Apr;36(4):441-51.

  3. Wong GW, Lim KH, Wan WK, Low SC, Kong SC. Eosinophilic gastroenteritis: Clinical profiles and treatment outcomes, a retrospective study of 18 adult patients in a Singapore Tertiary Hospital. Med J Malaysia. 2015 Aug;70(4):232-7.

  4. Tan IB, Malik S, Ramnarayanan K, McPherson JR, Ho DL, Suzuki Y, Ng SB, Yan S,  Lim KH, Koh D, Hoe CM, Chan CY, Ten R, Goh BK, Chung AY, Tan J, Chan CX, Tay ST, Alexander L, Nagarajan N, Hillmer AM, Tang CL, Chua C, Teh BT, Rozen S, Tan P. High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer. Genome Biol. 2015 Feb 12;16(1):32.

  5. Ang SF, Ng ES, Li H, Ong YH, Choo SP, Ngeow J, Toh HC, Lim KH, Yap HY, Tan CK, Ooi LL, Chung AY, Chow PK, Foo KF, Tan MH, Cheow PC. The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma. PLoS One. 2015 Apr 1;10(4):e0118658. JIF (2013): 3.534

  6. Das K, Gunasegaran B, Tan IB, Deng N, Lim KH, Tan P. Mutually exclusive FGFR2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH. Cancer Lett. 2014 Oct 28;353(2):167-75.

  7. Chan-On W, Nairismägi ML, Ong CK, Lim WK, Dima S, Pairojkul C, Lim KH, McPherson JR, Cutcutache I, Heng HL, Ooi L, Chung A, Chow P, Cheow PC, Lee SY, Choo SP, Tan IB, Duda D, Nastase A, Myint SS, Wong BH, Gan A, Rajasegaran V, Ng CC, Nagarajan S, Jusakul A, Zhang S, Vohra P, Yu W, Huang D, Sithithaworn P, Yongvanit P, Wongkham S, Khuntikeo N, Bhudhisawasdi V, Popescu I, Rozen SG, Tan P, Teh BT. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat Genet. 2013 Dec;45(12):1474-8.

Improving molecular profiling of childhood cancers with focus on neuroblastomas and tumours involving paediatric brain, soft tissue and kidney.